Lexicon Pharmaceuticals, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 1.48 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 658.53M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
Details
| Name | Lexicon Pharmaceuticals, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 81 |
| Founded | 1995 |
| Ipo Date | 2000-04-07 |
| Ceo | Michael Exton |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US5288723027 |
| Cusip | 528872302 |
| Cik | 0001062822 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Dr. Michael S. Exton Ph.D. | Chief Executive Officer and Director |
| Scott M. Coiante | Senior Vice President and Chief Financial Officer |
| Brian T. Crum | Senior Vice President, General Counsel and Secretary |
| Wendy E. McDermott | Senior Vice President of Human Resources |
| Dr. Craig B. Granowitz M.D., Ph.D. | Senior Vice President and Chief Medical Officer |
| Kristen L. Alexander | Vice President of Finance and Accounting |
| Lisa M. DeFrancesco | Senior Vice President of Investor Relations and Corporate Communications |
| Dr. Suma Gopinathan M.S., Ph.D. | Senior Vice President of Discovery |
| Rachel Yap Martens | Senior Vice President and Chief Commercial Officer |
Contact
| Address | 2445 Technology Forest Boulevard, 11th Floor, The Woodlands, Texas 77381, United States |
| Phone | 281 863 3000 |
| Website | https://www.lexpharma.com |